PTX3 and prostate carcinoma: Here, in agreement with previous findings [27], we show that PTX3 overexpression or treatment with the PTX3-derived small molecule FGF trap NSC12 result in a significant inhibition of the growth of TRAMP-C2 tumor grafts, a murine model of prostate cancer [20].